Trevi Therapeutics, Inc.
TRVI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $34 | $32 | $13 | $37 |
| Short-Term Investments | $74 | $51 | $108 | $0 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $5 | $2 | $1 |
| Total Curr. Assets | $109 | $88 | $123 | $38 |
| Property Plant & Equip (Net) | $1 | $2 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $2 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $111 | $89 | $123 | $38 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $3 | $3 |
| Short-Term Debt | $0 | $0 | $7 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $4 | $4 | $4 |
| Total Curr. Liab. | $11 | $6 | $13 | $13 |
| LT Debt | $1 | $1 | $2 | $9 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $2 | $9 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $0 |
| Total Liabilities | $11 | $7 | $16 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$287 | -$239 | -$210 | -$181 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $387 | $322 | $318 | $198 |
| Total Equity | $100 | $83 | $107 | $17 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $111 | $89 | $123 | $38 |
| Net Debt | -$33 | -$31 | -$3 | -$22 |